Events2Join

mRNA|based vaccines and therapeutics


mRNA-based vaccines and therapeutics: an in-depth survey of ...

mRNA-based drugs have tremendous potential as clinical treatments, however, a major challenge in realizing this drug class will promise to ...

mRNA-based therapeutics: looking beyond COVID-19 vaccines

Here, we will summarise the recent advances in mRNA technology; its use in vaccines, immunotherapeutics, protein replacement therapy, and genomic editing.

mRNA-based therapeutics: powerful and versatile tools to combat ...

The therapeutic use of messenger RNA (mRNA) has fueled great hope to combat a wide range of incurable diseases. Recent rapid advances in ...

Unlocking the promise of mRNA therapeutics | Nature Biotechnology

Perhaps the most critical advances in mRNA vaccines and therapeutics lie in the discovery that the inclusion of chemically modified nucleosides, ...

mRNA Technology: What It Is and How It Works - Pfizer

mRNA has proved to be a great platform for vaccine development (and potentially therapeutics), so that our own cells can do the hard work of producing proteins, ...

mRNA-based therapeutics: looking beyond COVID-19 vaccines

The rapid, potent, and transient nature of mRNA-encoded proteins, without the need to enter the nucleus or the risk of genomic integration, makes them desirable ...

mRNA medicines we are currently developing - Moderna

CANCER VACCINES & THERAPEUTICS · Individualized neoantigen therapy (INT) – adjuvant melanoma · Individualized neoantigen therapy (INT) – adjuvant NSCLC.

mRNA technology: vaccines and beyond - Sanofi

mRNA vaccines are designed to instruct certain cells in the body to produce a "mimic" of that viral or bacterial protein directly. This mimic ...

What are mRNA vaccines and how do they work? - MedlinePlus

mRNA vaccines use a piece of mRNA that corresponds to a protein on a virus. Vaccines for COVID-19 are the only mRNA vaccines authorized or ...

Review mRNA therapeutics: New vaccination and beyond

The mRNA vaccine emerges as a powerful and general tool against new viral infections, largely due to its versatility and rapid development.

Messenger RNA-Based Therapeutics and Vaccines: What's beyond ...

A significant amount of research has now been concentrated on developing mRNA drugs and vaccine platforms against infectious and immune diseases, cancer, and ...

The Delivery of mRNA Vaccines for Therapeutics - MDPI

mRNA vaccines promote both humoral and cellular immune responses and induce the innate immune system. Additionally, nucleoside modification in ...

mRNA vaccine: a potential therapeutic strategy - Molecular Cancer

The antigen-encoding mRNA vaccine is a promising candidate for its safety, the improved therapeutic efficacy and a large scale mRNA-vaccine ...

mRNA therapeutics: beyond vaccine applications - Cell Press

mRNAs can be widely used in vaccine development, protein replacement therapy, and the treatment of genetic diseases.

Moderna: Pioneering mRNA technology

mRNA medicines fight diseases in a different way than traditional medicine by prompting your immune system to create the tools to treat or prevent disease.

Vaccines and Beyond: Strategies and Technologies for mRNA ...

An expert panel will discuss mRNA-based vaccines, current approaches and challenges, and how researchers are moving RNA therapeutics forward in exciting new ...

mRNA therapies: current landscape and future possibilities

In the case of mRNA therapy for cancer, the mechanism of action is the same as for vaccines against pathogens- the mRNA transcripts are taken up ...

mRNA-Based Therapeutics Summit: Home

Join 400+ mRNA experts to fast-track mRNA-based therapeutics and vaccines from discovery to commercialization.

mRNA: a drug class of its own - BioNTech

mRNA has many uses as a cancer therapeutic and vaccine. Read more about the possibilities of this molecule and our technological breakthroughs.

mRNA Vaccines: A Bright Future in Vaccinology - Penn Medicine

Penn Medicine researchers have developed a mRNA-based vaccine against all 20 known subtypes of influenza virus. If clinical trials are successful, this ...